{
  "docId": "019de077-0326-7579-845c-ff13347b3147",
  "docSlug": "a6759fd47798a8f3f6e744ad8917865e",
  "documentTitle": "Exscientia | Investor Presentation Deck | 93 slides",
  "authorId": "exscientia",
  "authorName": "Exscientia",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2024-03-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 51,
  "pageCount": 93,
  "prevPage": 50,
  "nextPage": 52,
  "slideType": "solution",
  "function": "present_solution",
  "density": "overcrowded",
  "nDataPoints": 1,
  "notes": "The slide uses a three-column layout to define the target product profile (TPP) for a CDK7 inhibitor.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de077-0326-7579-845c-ff13347b3147/51",
  "deckHref": "/decks/019de077-0326-7579-845c-ff13347b3147",
  "deckJsonHref": "/decks/019de077-0326-7579-845c-ff13347b3147.json",
  "deckAnchorHref": "/decks/019de077-0326-7579-845c-ff13347b3147#slide-51",
  "components": [
    {
      "bbox": {
        "h": 0.15,
        "w": 0.28,
        "x": 0.67,
        "y": 0.71
      },
      "kind": "callout",
      "text": "Goal is for very rapid absorption at the lowest possible dose",
      "attrs": null,
      "subkind": "primary",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "462d8a57-9c9a-410b-b916-a8134b80edf4",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.28,
        "x": 0.37,
        "y": 0.71
      },
      "kind": "callout",
      "text": "Product needs to be highly potent, but with a short half-life",
      "attrs": null,
      "subkind": "primary",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "4cd02b07-bb35-4ef5-935c-ebc7a20530bc",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.28,
        "x": 0.07,
        "y": 0.71
      },
      "kind": "callout",
      "text": "Design needs to achieve potency and selectivity non-covalently",
      "attrs": null,
      "subkind": "primary",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "c5fe253f-a58b-4ba6-945a-669a664a316c",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.4,
        "w": 0.28,
        "x": 0.07,
        "y": 0.27
      },
      "kind": "list",
      "text": "Non-covalent Potency and Selectivity: Both potency and selectivity are critically important. Early entrants targeted higher potency and selectivity by covalent bonding. This dramatically increased off target toxicity, leading to discontinuation.",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "3f46a786-d31d-4d88-b42a-a2525f422db6",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.3,
        "w": 0.28,
        "x": 0.67,
        "y": 0.27
      },
      "kind": "list",
      "text": "Bioavailable: CDK7 inhibition will lead to toxicity if it remains at any site other than the tumour. Absorption variability will cause either supra-doses or sub-therapeutic dosing.",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "4e52dcca-caf9-4447-ba40-c7063cf06309",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.3,
        "w": 0.28,
        "x": 0.37,
        "y": 0.27
      },
      "kind": "list",
      "text": "Short Therapeutic Window: Ideal therapeutic coverage would be 8-10 hours at IC80. Longer periods would lead to increasing systemic toxicity.",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "f9681b0e-9d14-4052-9a62-127b11598090",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.04,
        "w": 0.6,
        "x": 0.07,
        "y": 0.13
      },
      "kind": "title",
      "text": "Mechanism requires a tightly controlled target product profile",
      "attrs": null,
      "subkind": "action-title",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "44310e40-94f0-412b-975b-aeefedd08b4c",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.5,
        "x": 0.07,
        "y": 0.06
      },
      "kind": "title",
      "text": "Precision design to maximise effectiveness",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "47eb5fab-fc9d-4cb0-bff5-3af72ec05a0b",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 76,
      "from": 40,
      "beatId": "5ac1e19c-a020-4b03-85c5-f8d4af660d2d",
      "arcName": "The Sparkline",
      "arcSlug": "sparkline",
      "beatName": "Traction",
      "beatSlug": null,
      "evidence": "Highlighting of Exscientia's achievements and partnerships",
      "position": 3,
      "confidence": 0.8,
      "parentBeatName": null,
      "parentBeatSlug": null
    }
  ],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}